American Well Corp (AMWL)
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
$12.99-1.96%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · AMWL
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -37.0% |
| Our one-year growth estimate | diamond | -2.8% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 34.2 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 21 industry peers · Company calendar date is not available
AMWL — legal / regulatory event — Changes in Registrant’s Certifying Accountant
Dated 2026-07-21
Changes in Registrant’s Certifying Accountant. On July 14, 2026, the Audit Committee of the board of directors of American Well Corporation (the “Company”) dismissed PricewaterhouseCoopers LLP (the “Former Auditor”) as the Company’s independent registered public accounting firm. The Former Auditor’s reports on the Company’s financial statements for the two most recent fiscal year ended December 31, 2025 and 2024 did not contain any adverse opinion or disclaimer of opinion and were not qualifi…
Why it matters: A bigger loss shows ongoing operational problems. This may affect cash flow goals.
Worry ifQ2 adjusted EBITDA was worse than ($4) million.
Less concerning ifQ2 adjusted EBITDA meets or exceeds ($4) million.
Why it matters: Earnings results will provide insight into financial health and growth prospects. Investors will be looking for signs of improvement.
Watch forEarnings report shows a positive surprise in revenue or earnings per share.
Also watch forEarnings report shows a negative surprise in revenue or earnings per share.
Why it matters: Meeting this target is key for growth and shows demand for their services.
Supportive ifReported AMG visits reach at least 1.32 million.
Worry ifAMG visits remain below 1.32 million.
Why it matters: Changes in leadership can change the company's path. This can also impact investor trust.
Worry ifThere is news of a new executive hire that fits strategic goals.
Less concerning ifMore key executives are leaving. There are no clear plans for their replacements.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$187 on $10,000 · ±1.9% | How much price usually moves either way. |
| Bad day | $496 loss on $10,000 · 5.0% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,124 loss on $10,000 · 21.2% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: This revenue range is a key test of Amwell's growth trajectory. Meeting it shows strong demand.
Supportive ifQ3 revenue reported at or above $46 million.
Worry ifQ3 revenue reported below $46 million.
Why it matters: A rise in Adjusted EBITDA shows progress toward making more money.
Supportive ifAdjusted EBITDA was reported at less than -$5 million.
Worry ifAdjusted EBITDA worsens to more than -$3 million.
Why it matters: Progress or setbacks in this partnership could impact growth. It is a key part of management's strategy.
Watch forThere is news about a new project or success with Elevance Health.
Also watch forNews of challenges or delays in the partnership with Elevance Health.
Why it matters: Changing auditors can raise worries about financial reports. This can hurt investor trust.
Worry ifAnnouncement of a new accounting firm by August 2026.
Less concerning ifNo announcement of a new auditor by the end of August 2026.
Why it matters: Reaffirming this guidance would show management's confidence despite recent revenue declines. It is key for investor trust.
Supportive ifManagement confirms the 2026 revenue goal in the next earnings call.
Worry ifManagement lowers the 2026 revenue goal to below $195M.
Why it matters: Faster revenue growth would be a good sign for American Well. It may show recovery in a growing sector.
Supportive ifQ2 revenue growth exceeds 10% year over year.
Worry ifQ2 revenue growth remains below 10% year over year.
Why it matters: Getting this visit range is important for Amwell's growth and service approval.
Supportive ifAMG visits reported at or above 1.32 million.
Worry ifAMG visits reported below 1.32 million.
Why it matters: Reaching this goal would be a big step for Amwell's financial health.
Supportive ifPositive cash flow from operations reported in Q4 2026.
Worry ifNegative cash flow from operations reported in Q4 2026.
Why it matters: Keeping this relationship is key for Amwell's growth and steady income.
Watch forThe DHA announced they will keep the relationship with good terms.
Also watch forThe DHA announced they will end or change the relationship in a bad way.